Technology Foundation to Accelerate
and Scale Product Development

  • Alexion Boehringer Ingelheim CSL Emmes GSK Moderna

¡°Our strategic partnership with ³Ô¹Ï±¬ÁÏ expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders ¨C this is key to how we measure success.¡±

-Robert M Davis, Chief Executive Officer and President, Merck

Read the Press Release

Greater Efficiency and Innovation

GSK
Standardizing Common Data and Processes Across R&D

Sarepta
Time Savings and Data Consistency with Regulatory and Quality Connection

Argenx
Greater Efficiency and Transparency with ³Ô¹Ï±¬ÁÏ Development Cloud

Idorsia
Why Idorsia Standardized on Clinical, Quality, and Regulatory

LEO
Streamlining Product Development with a Unified Platform

Inhibrx
Deploying an R&D System Foundation in 4.5 Months

Alexion
Alexion Supports Rapid Growth with ³Ô¹Ï±¬ÁÏ Development Cloud

Boehringer Ingelheim
How Boehringer Ingelheim Deepened its Digital Transformation

Lysarc
LYSARC Partners with ³Ô¹Ï±¬ÁÏ to Accelerate Innovation for Lymphoma Treatments

Emmes
Emmes Standardizes on ³Ô¹Ï±¬ÁÏ Development Cloud to Streamline Product Development

Gilead, AbbVie
Best Practices for Bringing Acquired Companies into a ³Ô¹Ï±¬ÁÏ Environment

Interested in learning more about how ³Ô¹Ï±¬ÁÏ can help?